Yun Soo Kim

4PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyPredictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 27, 2025
Current Landscape of Adoptive Cell Therapy and Challenge to Develop "Off-The-Shelf" Therapy for Hepatocellular Carcinoma.

Seung Kak Shin, Yuta Mishima, Yoonseok Lee

|Nov 25, 2020
Seroreversion and Acute Decompensation in Chronic Hepatitis B after Discontinuation of Oral Nucleotide Analog in the Patients Achieving HBsAg Loss.

Hye Jeong Cho, Seung Kak Shin, Oh Sang Kwon

|Oct 29, 2020
Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis.

Seung Kak Shin, Hyung Joon Yim, Jeong Han Kim

|Oct 26, 2019
Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study.

Seung Kak Shin, Jin Woo Lee, Hannah Ra

Pageof 1

Frequent Collaborators

3 joint publications

Seung Kak Shin

2 joint publications

Oh Sang Kwon

2 joint publications

Ju Hyun Kim

1 joint publications

Jin Woo Lee